101 related articles for article (PubMed ID: 10088172)
1. Reproducibility of 99Tcm-MAG3 clearance.
Boivin C
Nucl Med Commun; 1999 Feb; 20(2):199-200. PubMed ID: 10088172
[No Abstract] [Full Text] [Related]
2. Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH.
Kanazawa T; Shimizu M; Seto H; Kageyama M; Kameda K; Toyoshima S; Tomizawa G; Watanabe N; Inagaki S
Nucl Med Commun; 1998 Sep; 19(9):899-903. PubMed ID: 10581597
[TBL] [Abstract][Full Text] [Related]
3. Monitoring renal function: a prospective study comparing camera-based technetium-99m mercaptoacetyltriglycine clearance and creatinine clearance.
Halkar R; Taylor A; Manatunga A; Issa MM; Myrick SE; Grant S; Shenvi NV
Urology; 2007 Mar; 69(3):426-30. PubMed ID: 17382136
[TBL] [Abstract][Full Text] [Related]
4. Plasma clearance of 99Tc(m)-MAG3: accuracy of five single-sample methods.
Piepsz A; De Sadeleer C; Ham HR
Nucl Med Commun; 2000 Dec; 21(12):1160-2. PubMed ID: 11200021
[No Abstract] [Full Text] [Related]
5. Reproducibility of a single-sample method for 99Tcm-MAG3 clearance under clinical conditions.
Kotzerke J; Glatz S; Grillenberger K; Kleinschmidt K; Reske SN
Nucl Med Commun; 1997 Apr; 18(4):352-7. PubMed ID: 9170621
[TBL] [Abstract][Full Text] [Related]
6. Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient.
Murthy R; Chahal M; Appel G; Bergmann S; Tikofsky R; Fawwaz R; Van Heertum R
Clin Nucl Med; 2006 Dec; 31(12):829-34. PubMed ID: 17117088
[TBL] [Abstract][Full Text] [Related]
7. Plasma clearance of 99Tcm-MAG3: accuracy of five single-sample methods.
Rehling M; Nielsen LE
Nucl Med Commun; 2000 Feb; 21(2):193-7. PubMed ID: 10758616
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of (99m)Tc-MAG3.
Vivier PH; Dacher JN
AJR Am J Roentgenol; 2009 Oct; 193(4):W361; author reply W362. PubMed ID: 19770310
[No Abstract] [Full Text] [Related]
10. Radiopharmacokinetics, renal clearance and dosimetry of 99mTc-MAG3.
Arteaga de Murphy C; Molina-Trinidad E; Meléndez-Alafort L; Ferro-Flores G; Reyes-Herrera L; Sepúlveda-Méndez J; Sandoval-Guzmán B; Hoyo-Vadillo C
Arch Med Res; 1999; 30(1):49-54. PubMed ID: 10071425
[TBL] [Abstract][Full Text] [Related]
11. Estimation of 99Tcm-MAG3 clearance using a single blood sample obtained over a continuous time interval.
Piera C; Ros D; Pavia J; Fuster D; Muxi A
Nucl Med Commun; 1997 Jan; 18(1):60-5. PubMed ID: 9061703
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the reproducibility of Technetium-99m mercaptoacetyltriglycine clearance.
De Sadeleer C
Nucl Med Rev Cent East Eur; 2005; 8(1):15-20. PubMed ID: 15977142
[TBL] [Abstract][Full Text] [Related]
13. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
14. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance.
Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L
Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian 3-compartment model for 99mTc-MAG3 clearance.
Russell CD
J Nucl Med; 2003 Aug; 44(8):1357-61. PubMed ID: 12902428
[TBL] [Abstract][Full Text] [Related]
16. Simplified algorithms for the estimation of 99Tcm-MAG3 clearance.
De Sadeleer C; Piepsz A; Tondeur M; Ham HR
Nucl Med Commun; 2000 Jan; 21(1):65-9. PubMed ID: 10717904
[TBL] [Abstract][Full Text] [Related]
17. Deadtime correction in measurement of fractional renal accumulation of 99Tcm-MAG3.
Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Ohtomo K
Nucl Med Commun; 1999 Mar; 20(3):267-72. PubMed ID: 10093077
[TBL] [Abstract][Full Text] [Related]
18. How gender and age affect iodine-131-OIH and technetium-99m-MAG3 clearance.
Bagni B; Bagni I; Orsolon P; Corazzari T
J Nucl Med Technol; 2000 Sep; 28(3):156-8. PubMed ID: 11001496
[TBL] [Abstract][Full Text] [Related]
19. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
Afshan A; Sohaib M; Jehangir M
Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
